Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbonic anhydrase 5B pseudogene 1 (CA5BP1) is classified as a pseudogene located adjacent to the functional CA5B gene. Pseudogenes are DNA sequences similar to functional genes but generally lack the ability to encode a functional protein, either due to mutations or incomplete sequences. CA5BP1 is predicted to potentially possess carbonate dehydratase activity and to localize to the mitochondrion, based on sequence similarity, but there is no evidence it produces a functional enzyme or plays a significant biological role. It is not implicated in disease or normal physiological processes and is not a therapeutic target[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbonic anhydrase 5B pseudogene 1 (CA5BP1 or CA5BP).